PVG Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,062
Closed -$205K 107
2025
Q3
$205K Sell
8,062
-202
-2% -$4.99K 0.76% 61
2025
Q2
$200K Sell
8,264
-3,370
-29% -$78.6K 0.68% 53
2025
Q1
$295K Sell
11,634
-13,745
-54% -$360K 1.28% 22
2024
Q4
$673K Buy
+25,379
New +$688K 3.19% 10
2020
Q1
Sell
-23,367
Closed -$869K 78
2019
Q4
$869K Buy
23,367
+13,171
+129% +$469K 1.21% 21
2019
Q3
$348K Buy
+10,196
New +$371K 0.38% 62
2019
Q2
Sell
-24,451
Closed -$985K 81
2019
Q1
$985K Buy
+24,451
New +$979K 0.89% 41
2018
Q1
Sell
-43,324
Closed -$1.49M 106
2017
Q4
$1.49M Sell
43,324
-7,388
-15% -$252K 0.68% 43
2017
Q3
$1.72M Sell
50,712
-8,937
-15% -$287K 0.75% 41
2017
Q2
$1.9M Sell
59,649
-19,432
-25% -$613K 0.72% 39
2017
Q1
$2.57M Buy
79,081
+22,052
+39% +$695K 0.79% 44
2016
Q4
$1.76M Sell
57,029
-17,982
-24% -$549K 0.74% 42
2016
Q3
$2.41M Buy
75,011
+1,450
+2% +$48.5K 1.02% 34
2016
Q2
$2.46M Sell
73,561
-43,081
-37% -$1.37M 1.02% 29
2016
Q1
$3.28M Buy
+116,642
New +$3.33M 1.28% 29

Other funds holding PFE

PVG Asset Management's PFE Position: Q4 2025 in Review

PVG Asset Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 8,062 shares — an estimated $205K sold.

PVG Asset Management first reported a position in PFE in Q1 2016 and held it in 15 quarters. The position peaked at $3.28M in Q1 2016. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • PVG Asset Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • PVG Asset Management sold 8,062 Pfizer shares in Q4 2025, an estimated $205K.
  • PVG Asset Management first reported a position in Pfizer in Q1 2016 and held it in 15 quarters.
  • PVG Asset Management's Pfizer position peaked at $3.28M in Q1 2016.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on PVG Asset Management's 13F filing for Q4 2025, filed 30 Jan 2026.